Humana Inc. beat EPS estimates 88% of the time across 16 reported quarters (14 beats, 2 misses), averaging +5.6% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | $6.22 | $7.61 | +22.4% | Beat | Q2 FY26 call |
| Q1 FY26 | $9.97 | $10.31 | +3.4% | Beat | Q1 FY26 call |
| Q4 FY25 | $-4.01 | $-3.96 | +1.3% | Beat | Q4 FY25 call |
| Q3 FY25 | $2.91 | $3.24 | +11.3% | Beat | |
| Q2 FY25 | $6.32 | $6.27 | -0.8% | Miss | Q2 FY25 call |
| Q1 FY25 | $9.98 | $11.58 | +16.0% | Beat | |
| Q4 FY24 | $-2.24 | $-2.16 | +3.6% | Beat | |
| Q3 FY24 | $3.48 | $4.16 | +19.5% | Beat | |
| Q2 FY24 | $5.89 | $6.96 | +18.2% | Beat | |
| Q1 FY24 | $6.02 | $7.23 | +20.1% | Beat | |
| Q4 FY23 | $-0.07 | $-0.11 | -57.1% | Miss | |
| Q3 FY23 | $7.15 | $7.78 | +8.8% | Beat |
Back to HUM overview · HUM holders · HUM KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.